Add BrightSurf on Google Email

Search results for “Hematology”

1,000+ results for "Hematology"

Study reveals no impact of age on outcome in chronic myeloid leukemia patients treated with imatinib

A study published in Blood reveals that imatinib treatment has no significant impact on the outcome of chronic myeloid leukemia (CML) patients aged 65 and older. The research found that complete hematologic response rates, cytogenetic response rates, and overall survival rates were similar between younger and older patients treated wit...

Study identifies promising treatment for aggressive lymphoma

A study published in the American Society of Clinical Oncology annual meeting showed that lenalidomide significantly improved response rates and complete remission in patients with transformed lymphoma. Patients treated with lenalidomide had a remarkable response rate, with some experiencing complete remission for over a year.

SourceMayo Clinic·JournalJournal of Clinical Oncology·DateMay 26, 2010

Key player found for a cancer typical in Down syndrome

A gene regulator, miR-125b-2, has been identified as a key player in the development of leukemia typical of Down syndrome. The over-expression of this microRNA is found to be necessary for the disease's progression. Further studies suggest that miR-125b-2 silences tumor-suppression genes and regulatory microRNAs, spurting the leukemia.

SourceBoston Children's Hospital·JournalGenes & Development·DateMar 1, 2010

Offering hope for tissue regeneration

Scientists at Rhode Island Hospital have discovered a novel mechanism of cell-to-cell communication using microvesicles, which can reprogram stem cells to behave like healthy cells. This finding offers hope for tissue regeneration and potential treatments for diseases such as cancer.

SourceLifespan·JournalExperimental Hematology·DateFeb 26, 2010

Improving the odds

Scientists at Weizmann Institute of Science have developed a new method for transplanting bone marrow-based stem cells from mismatched donors, restoring the immune system faster and improving cure rates for leukemia patients. The procedure involves infusing regulatory T cells into cancer patients before receiving donor stem cells, lead...